Bayban’s Organon & Co OGN Stock Holding History

Bayban’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04K	Buy	77 +20	+35%	+$239	﹤0.01%	562
2026 Q1	$341	Hold	57	–	–	﹤0.01%	658
2025 Q4	$409	Buy	+57	New	+$450	﹤0.01%	601

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bayban's OGN Position: Q2 2026 in Review

Bayban increased its Organon & Co (OGN) stake by 35% in Q2 2026, buying an estimated $239 and bringing the position to 77 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #562.

Bayban first reported a position in OGN in Q4 2025 and has held it in 3 quarters since. 594 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Bayban held 77 shares of Organon & Co worth $1.04K as of Q2 2026.
Bayban bought 20 Organon & Co shares in Q2 2026, an estimated $239.
Organon & Co made up ﹤0.01% of Bayban's portfolio in Q2 2026, its #562 holding.
Bayban first reported a position in Organon & Co in Q4 2025 and has held it in 3 quarters since.
594 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bayban's 13F filing for Q2 2026, filed 30 Jul 2026.